916 related articles for article (PubMed ID: 28939716)
1. Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.
Viazzi F; Piscitelli P; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939716
[TBL] [Abstract][Full Text] [Related]
2. Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes.
Viazzi F; Greco E; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
Kidney Blood Press Res; 2018; 43(2):422-438. PubMed ID: 29698970
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes.
De Cosmo S; Viazzi F; Piscitelli P; Giorda C; Ceriello A; Genovese S; Russo G; Guida P; Fioretto P; Pontremoli R;
J Hypertens; 2016 Oct; 34(10):2090-8. PubMed ID: 27457667
[TBL] [Abstract][Full Text] [Related]
4. Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes.
Viazzi F; Piscitelli P; Giorda C; Ceriello A; Genovese S; Russo GT; Fioretto P; Guida P; De Cosmo S; Pontremoli R;
J Diabetes Complications; 2017 Feb; 31(2):419-426. PubMed ID: 27884661
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
Thomas G; Xie D; Chen HY; Anderson AH; Appel LJ; Bodana S; Brecklin CS; Drawz P; Flack JM; Miller ER; Steigerwalt SP; Townsend RR; Weir MR; Wright JT; Rahman M;
Hypertension; 2016 Feb; 67(2):387-96. PubMed ID: 26711738
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease.
de Beus E; Bots ML; van Zuilen AD; Wetzels JF; Blankestijn PJ;
Hypertension; 2015 Nov; 66(5):998-1005. PubMed ID: 26351024
[TBL] [Abstract][Full Text] [Related]
7. Annual deterioration of renal function in hypertensive patients with and without diabetes.
Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S
Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063
[TBL] [Abstract][Full Text] [Related]
8. Changes in albuminuria and renal outcome in patients with type 2 diabetes and hypertension: a real-life observational study.
Viazzi F; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; Greco E; De Cosmo S; Pontremoli R;
J Hypertens; 2018 Aug; 36(8):1719-1728. PubMed ID: 29677050
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.
Chen J; Bundy JD; Hamm LL; Hsu CY; Lash J; Miller ER; Thomas G; Cohen DL; Weir MR; Raj DS; Chen HY; Xie D; Rao P; Wright JT; Rahman M; He J
Hypertension; 2019 Apr; 73(4):785-793. PubMed ID: 30776971
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.
de Beus E; van der Sande NGC; Bots ML; Spiering W; Voskuil M; Visseren FLJ; Blankestijn PJ
BMJ Open; 2017 Sep; 7(9):e016692. PubMed ID: 28882918
[TBL] [Abstract][Full Text] [Related]
12. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
[TBL] [Abstract][Full Text] [Related]
13. Decreased systolic blood pressure is associated with increased risk of all-cause mortality in patients with type 2 diabetes and renal impairment: A nationwide longitudinal observational study of 27,732 patients based on the Swedish National Diabetes Register.
Svensson MK; Afghahi H; Franzen S; Björk S; Gudbjörnsdottir S; Svensson AM; Eliasson B
Diab Vasc Dis Res; 2017 May; 14(3):226-235. PubMed ID: 28467201
[TBL] [Abstract][Full Text] [Related]
14. Risk Prediction for Early CKD in Type 2 Diabetes.
Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
[TBL] [Abstract][Full Text] [Related]
15. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease.
Mallamaci F; Minutolo R; Leonardis D; D'Arrigo G; Tripepi G; Rapisarda F; Cicchetti T; Maimone I; Enia G; Postorino M; Santoro D; Fuiano G; De Nicola L; Conte G; Zoccali C
Kidney Int; 2013 Aug; 84(2):381-9. PubMed ID: 23615498
[TBL] [Abstract][Full Text] [Related]
16. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function.
Gu L; Huang L; Wu H; Lou Q; Bian R
Diab Vasc Dis Res; 2017 May; 14(3):221-225. PubMed ID: 28183204
[TBL] [Abstract][Full Text] [Related]
17. Decreased glomerular filtration rate in patients with at least 5 years of type 2 diabetes in Ho Chi Minh City, Vietnam: Prevalence and associated factors.
Le HT; Le TT; Tran NMT; Nguyen TTT; Minh NCS; Le QT; Tram TAT; Tran TD; Doan TX; Thai TT
Prim Care Diabetes; 2020 Apr; 14(2):173-180. PubMed ID: 31494076
[TBL] [Abstract][Full Text] [Related]
18. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases.
Bramlage P; Lanzinger S; van Mark G; Hess E; Fahrner S; Heyer CHJ; Friebe M; Seufert J; Danne T; Holl RW
Cardiovasc Diabetol; 2019 Mar; 18(1):33. PubMed ID: 30878037
[TBL] [Abstract][Full Text] [Related]
19. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study.
Mielke J; Trucks-Jansen H; Schurmann C; Kotsis F; Köttgen A; Schneider MP; Eckardt KU; ; Freitag DF; Eitner F; Becker MS
J Hum Hypertens; 2023 May; 37(5):345-353. PubMed ID: 35534618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
